JPRN-UMIN000007458已完成1 期
Phase I study of combination chemotherapy with irinotecan hydrochroride(CPT-11) and nedaplatin(NDP) for locally advanced stage Ib2-IVa cervical cancer after Concurrent chemoradiotherapy (CCRT) - Phase I study of combination chemotherapy with CPT-11 and NDP for cervical cancer after CCRT
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients with serious complications 2) Patients with active infections 3) Patients with active concomitant malignancy 4) Patients underwent exploratory laparotomy 5) Patients with interstitial pneumonia or pulmonary fibrosis 6) Patients with massive pleural, cardiac effusion, and/or ascites 7) Patients with coneraindication to CPT-11or NDP 8) Patients with diarrhea (watery stool) 9) Patients with any history of serious drug reactions or hypersensitivity 10) Patients with HBs antigen 11) Patients treated with radiation therapy of the paraaortic lymph nodes in cervical carcinoma 12) Patients with progression of cervical carcinoma disease during concurrent chemoradiotherapy(CCRT) 13)Patients are inappropriate to enter this study with any safety reasons, judged by the treating physician
研究者
相似试验
已完成
不适用
Phase II study of concurrent chemotherapy with itraconazole in advanced gynecologic tumors.Gynecologic cancerJPRN-UMIN000013951Department of Obstetrics and Gynecology, Hyogo College of Medicine16
已完成
2 期
A phase ll study of adjuvant chemotherapy with Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage lb2 or lla node-positive cervical cancerStage lb2 lla cervical cancer with pelvic lymph node metastasisJPRN-UMIN000003036Japanese Gynecologic Oncology Group63
已完成
1 期
A phase 1 study of a combination chemotherapy, Sorafenib and intrahepatic arterial infusion of IA-call® (DDP-H), for advanced hepatocellular carcinoma.Hepatocellular carcinomaJPRN-UMIN000003831iigata Hepatocellular Carcinoma Therapy Study Group15
已完成
1 期
Phase I/II study of combination chemotherapy with Paclitaxel and TS-1 and Cisplatin for unresectable/ recurrent gastric cancerunresectable or recurrent gastric cancerJPRN-UMIN000004729School of Medicine, Keio University40
已完成
1 期
Phase I-II study of combination chemotherapy with Irinotecan and Gemcitabine for clear cell or mucinous ovarian cancerClear cell or mucinous ovarian cancerJPRN-UMIN000005952Osaka university, faculty of medicine40